BioXcel Therapeutics (BTAI) Interest Coverage Ratio (2022 - 2025)
Historic Interest Coverage Ratio for BioXcel Therapeutics (BTAI) over the last 4 years, with Q3 2025 value amounting to 3.25.
- BioXcel Therapeutics' Interest Coverage Ratio rose 1936.74% to 3.25 in Q3 2025 from the same period last year, while for Sep 2025 it was 3.05, marking a year-over-year increase of 4217.97%. This contributed to the annual value of 4.44 for FY2024, which is 6555.07% up from last year.
- As of Q3 2025, BioXcel Therapeutics' Interest Coverage Ratio stood at 3.25, which was up 1936.74% from 3.75 recorded in Q2 2025.
- BioXcel Therapeutics' Interest Coverage Ratio's 5-year high stood at 2.53 during Q1 2025, with a 5-year trough of 4497.14 in Q1 2022.
- Its 4-year average for Interest Coverage Ratio is 308.54, with a median of 6.7 in 2024.
- Over the last 5 years, BioXcel Therapeutics' Interest Coverage Ratio had its largest YoY gain of 9966.19% in 2023, and its largest YoY loss of 4093.48% in 2023.
- Over the past 4 years, BioXcel Therapeutics' Interest Coverage Ratio (Quarter) stood at 18.11 in 2022, then skyrocketed by 68.06% to 5.79 in 2023, then soared by 55.02% to 2.6 in 2024, then dropped by 25.02% to 3.25 in 2025.
- Its last three reported values are 3.25 in Q3 2025, 3.75 for Q2 2025, and 2.53 during Q1 2025.